HIF-2 directly activates CD82 gene expression in endothelial cells

Biochemical and Biophysical Research Communications

Volumn 407, Issue 1, 2011, Pages 260-265

  Nagao, Kaori ^a   Oka, Kiyomasa ^b  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

CD82; DNA microarray; Endothelial cell; HIF 2; Hypoxia

Indexed keywords

ALCOHOL; ANGIOPOIETIN 2; BETA ACTIN; CD82 ANTIGEN; HEXOSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; MESSENGER RNA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ARTICLE; CELL MIGRATION; CELL MOTILITY; COMPARATIVE STUDY; DNA MICROARRAY; GENE EXPRESSION; GLYCOLYSIS; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOBLOTTING; IN VITRO STUDY; INTRON; PRIORITY JOURNAL; PROTEIN FUNCTION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION;

BASE SEQUENCE; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HUMANS; KANGAI-1 PROTEIN; MOLECULAR SEQUENCE DATA;

EID: 79953162448     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.03.017     Document Type: Article

References (33)

1. Tian H., McKnight S.L., Russell D.W. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev. 1997, 11:72-82.
2. Gordan J.D., Bertout J.A., Hu C.J., Diehl J.A., Simon M.C. HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. Cancer Cell 2007, 11:335-347.
3. Maltepe E., Schmidt J.V., Baunoch D., Bradfield C.A., Simon M.C. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 1997, 386:403-407.
4. Kozak K.R., Abbott B., Hankinson O. ARNT-deficient mice and placental differentiation. Dev. Biol. 1997, 191:297-305.
5. Carmeliet P., Dor Y., Herbert J.M., Fukumura D., Brusselmans K., Dewerchin M., Neeman M., Bono F., Abramovitch R., Maxwell P., Koch C.J., Ratcliffe P., Moons L., Jain R.K., Collen D., Keshert E. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 1998, 394:485-490.
6. 2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev. 1998, 12:149-162.
7. Ryan H.E., Lo J., Johnson R.S. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J. 1998, 17:3005-3015.
8. Tian H., Hammer R.E., Matsumoto A.M., Russell D.W., McKnight S.L. The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev. 1998, 12:3320-3324.
9. Peng J., Zhang L., Drysdale L., Fong G.H. The transcription factor EPAS-1/hypoxia-inducible factor 2alpha plays an important role in vascular remodeling. Proc. Natl. Acad. Sci. USA 2000, 97:8386-8391.
10. Covello K.L., Simon M.C., Keith B. Targeted replacement of hypoxia-inducible factor-1alpha by a hypoxia-inducible factor-2alpha knock-in allele promotes tumor growth. Cancer Res. 2005, 65:2277-2286.
11. Hu C.J., Wang L.Y., Chodosh L.A., Keith B., Simon M.C. Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol. Cell. Biol. 2003, 23:9361-9374.
12. Wang V., Davis D.A., Haque M., Huang L.E., Yarchoan R. Differential gene up-regulation by hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha in HEK293T cells. Cancer Res. 2005, 65:3299-3306.
13. Rankin E.B., Biju M.P., Liu Q., Unger T.L., Rha J., Johnson R.S., Simon M.C., Keith B., Haase V.H. Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo. J. Clin. Invest. 2007, 117:1068-1077.
14. Dutta D., Ray S., Vivian J.L., Paul S. Activation of the VEGFR1 chromatin doma, an angiogenic signal-ETS1/HIF-2alpha regulatory axis. J. Biol. Chem. 2008, 283:25404-25413.
15. Licht A.H., Muller-Holtkamp F., Flamme I., Breier G. Inhibition of hypoxia-inducible factor activity in endothelial cells disrupts embryonic cardiovascular development. Blood 2006, 107:584-590.
16. Jackson P., Marreiros A., Russell P.J. KAI1 tetraspanin and metastasis suppressor. Int. J. Biochem. Cell Biol. 2005, 37:530-534.
17. Liu W.M., Zhang X.A. KAI1/CD82 a tumor metastasis suppressor. Cancer Lett. 2006, 240:183-194.
18. Yanez-Mo M., Barreiro O., Gordon-Alonso M., Sala-Valdes M., Sanchez-Madrid F. Tetraspanin-enriched microdomains: a functional unit in cell plasma membranes. Trends Cell Biol. 2009, 19:434-446.
19. Odintsova E., Sugiura T., Berditchevski F. Attenuation of EGF receptor signaling by a metastasis suppressor, the tetraspanin CD82/KAI-1. Curr. Biol. 2000, 10:1009-1012.
20. Takahashi M., Sugiura T., Abe M., Ishii K., Shirasuna K. Regulation of c-Met signaling by the tetraspanin KAI-1/CD82 affects cancer cell migration. Int. J. Cancer 2007, 121:1919-1929.
21. Hemler M.E. Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. Annu. Rev. Cell Dev. Biol. 2003, 19:397-422.
22. Berditchevski F., Odintsova E. Tetraspanins as regulators of protein trafficking. Traffic 2007, 8:89-96.
23. Odintsova E., Butters T.D., Monti E., Sprong H., van Meer G., Berditchevski F. Gangliosides play an important role in the organization of CD82-enriched microdomains. Biochem. J. 2006, 400:315-325.
24. Vitorino P., Meyer T. Modular control of endothelial sheet migration. Genes Dev. 2008, 22:3268-3281.
25. Abe M., Sugiura T., Takahashi M., Ishii K., Shimoda M., Shirasuna K. A novel function of CD82/KAI-1 on E-cadherin-mediated homophilic cellular adhesion of cancer cells. Cancer Lett. 2008, 266:163-170.
26. Elvert G., Kappel A., Heidenreich R., Englmeier U., Lanz S., Acker T., Rauter M., Plate K., Sieweke M., Breier G., Flamme I. Cooperative interaction of hypoxia-inducible factor-2alpha (HIF-2alpha) and Ets-1 in the transcriptional activation of vascular endothelial growth factor receptor-2 (Flk-1). J. Biol. Chem. 2003, 278:7520-7530.
27. Le Bras A., Lionneton F., Mattot V., Lelievre E., Caetano B., Spruyt N., Soncin F. HIF-2alpha specifically activates the VE-cadherin promoter independently of hypoxia and in synergy with Ets-1 through two essential ETS-binding sites. Oncogene 2007, 26:7480-7489.
28. Sowter H.M., Raval R.R., Moore J.W., Ratcliffe P.J., Harris A.L. Predominant role of hypoxia-inducible transcription factor (HIF)-1alpha versus HIF-2alpha in regulation of the transcriptional response to hypoxia. Cancer Res. 2003, 63:6130-6134.
29. Hu C.J., Sataur A., Wang L., Chen H., Simon M.C. The N-terminal transactivation domain confers target gene specificity of hypoxia-inducible factors HIF-1alpha and HIF-2alpha. Mol. Biol. Cell 2007, 18:4528-4542.
30. Ruseva Z., Geiger P.X., Hutzler P., Kotzsch M., Luber B., Schmitt M., Gross E., Reuning U. Tumor suppressor KAI1 affects integrin alphavbeta3-mediated ovarian cancer cell adhesion, motility, and proliferation. Exp. Cell Res. 2009, 315:1759-1771.
31. Adams R.H., Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat. Rev. Mol. Cell Biol. 2007, 8:464-478.
32. Takeda Y., Kazarov A.R., Butterfield C.E., Hopkins B.D., Benjamin L.E., Kaipainen A., Hemler M.E. Deletion of tetraspanin Cd151 results in decreased pathologic angiogenesis in vivo and in vitro. Blood 2007, 109:1524-1532.
33. Skuli N., Liu L., Runge A., Wang T., Yuan L., Patel S., Iruela-Arispe L., Simon M.C., Keith B. Endothelial deletion of hypoxia-inducible factor-2alpha (HIF-2alpha) alters vascular function and tumor angiogenesis. Blood 2009, 114:469-477.